Molecular Mechanisms of Sensorineural Hearing Loss and Development of Inner Ear Therapeutics
| Molecular Mechanisms of Sensorineural Hearing Loss and Development of Inner Ear Therapeutics |
| Autore | Vlajkovic Srdjan M |
| Pubbl/distr/stampa | Basel, Switzerland, : MDPI - Multidisciplinary Digital Publishing Institute, 2021 |
| Descrizione fisica | 1 online resource (5793 p.) |
| Soggetto topico | Medicine and Nursing |
| Soggetto non controllato |
adenosine A1 receptor
adjunctive therapy age-related hearing loss aging astrocytes auditory brainstem brain-derived neurotrophic factor CCG-4986 chronic oral treatment circadian dysregulation clock genes cochlear nucleus cochlear rescue d-galactose deafness development gap junctions hearing loss hearing protection high-fat diet hyperbaric oxygenation hypoxic inferior colliculus inner ear intratympanic drug delivery KCNQ4 activator lateral superior olive microRNAs mitochondria dysfunction mouse model n/a neuroplasticity noise-induced cochlear injury noise-induced hearing loss nonsyndromic hearing loss otoferlin otoprotection potassium potassium voltage-gated channel subfamily q member 4 reactive oxygen species regulator of G protein signalling 4 selegiline sensorineural hearing loss sensory hair cells spontaneous activity synaptic ribbons TrkB voltage-activated calcium channel 1.3 zebrafish |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Record Nr. | UNINA-9910557463003321 |
Vlajkovic Srdjan M
|
||
| Basel, Switzerland, : MDPI - Multidisciplinary Digital Publishing Institute, 2021 | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Understanding Neuromuscular Health and Disease: Advances in Genetics, Omics, and Molecular Function
| Understanding Neuromuscular Health and Disease: Advances in Genetics, Omics, and Molecular Function |
| Autore | Duddy William |
| Pubbl/distr/stampa | Basel, Switzerland, : MDPI - Multidisciplinary Digital Publishing Institute, 2021 |
| Descrizione fisica | 1 online resource (318 p.) |
| Soggetto topico | Research & information: general |
| Soggetto non controllato |
-omics approaches
AAV adult patients ALS ALS genes ALS pathology ALS variants Amyotrophic Lateral Sclerosis autophagy axonal transport Becker muscular dystrophy becker muscular dystrophy (BMD) biomarkers calprotectin Canadian Neuromuscular Disease Registry clinical trials comparative genomic hybridization array (CGH) corticosteroids CRISPR-Cas9 D4Z4 deflazacort disease heterogeneity disease models disease modifiers DMARD DMD Duchenne muscular dystrophy duchenne muscular dystrophy (DMD) Duchenne muscular dystrophy (DMD) DUX4 dystrophin dystrophinopathy dystrophy Emery-Dreifuss muscular dystrophy endocytosis epigenetic changes eteplirsen excitotoxicity exon skipping exon skipping therapy exon-skipping therapies facioscapulohumeral dystrophy FSHD functional outcomes gene editing gene prioritization gene therapy genetic neuromuscular disorders genome-wide association studies genomics genotype-phenotype genotype-phenotype correlations glucocorticoids golodirsen GWAS LMNA machine learning methotrexate miRNA mitochondria dysfunction MND multiple logistic regression analysis multiplex ligation probe amplification (MLPA) multiplex polymerase chain reaction (PCR) muscle n/a neuromuscular diseases next-generation sequencing (NGS) Nusinersen Omics oxidative stress pharmacodynamic biomarkers pharmacogenomics polyadenylation precision medicine prednisone proteomics reading frame rule regulation rheumatoid arthritis RNA metabolism safety Sanger sequencing secretion skip-equivalent deletions SMA SNP spinal muscular atrophy TALEN toxicity transcription translational research viltolarsen XLMTM |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Altri titoli varianti | Understanding Neuromuscular Health and Disease |
| Record Nr. | UNINA-9910557669103321 |
Duddy William
|
||
| Basel, Switzerland, : MDPI - Multidisciplinary Digital Publishing Institute, 2021 | ||
| Lo trovi qui: Univ. Federico II | ||
| ||